| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |